Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Eder

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 7, 2023
Helicobacter pylori infection is associated with increased accumulation of advanced glycation end products in the skin in patients with type 1 diabetes: A preliminary studyAgnieszka Ewa Zawada, Dariusz Naskręt, Stanisław Piłaciński, et al.
Journal of Applied Genetics|September 2, 2023
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patientsLiliana Lykowska-Szuber, Michal Walczak, Kamila Stawczyk-Eder, et al.
Archives of Medical Science : AMS|May 22, 2015
Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative studyKamila Stawczyk-Eder, Piotr Eder, Liliana Lykowska-Szuber, et al.
Scientific Reports|May 21, 2015
Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodiesPiotr Eder, Michal Michalak, Katarzyna Katulska, et al.
Archives of Medical Science : AMS|January 21, 2016
Disturbances in apoptosis of lamina propria lymphocytes in Crohn's diseasePiotr Eder, Liliana Łykowska-Szuber, Iwona Krela-Kaźmierczak, et al.
Przeglad Gastroenterologiczny|October 8, 2016
Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agentsPiotr Eder, Liliana Łykowska-Szuber, Katarzyna Katulska, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 22, 2020
Milk and dairy product consumption in patients with inflammatory bowel disease: Helpful or harmful to bone mineral density?Iwona Krela-Kaźmierczak, Michał Michalak, Aleksandra Szymczak-Tomczak, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 21, 2018
Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseasesIwona Krela-Kaźmierczak, Aleksandra Szymczak-Tomczak, Liliana Łykowska-Szuber, et al.
Folia Histochemica Et Cytobiologica|June 9, 2016
The influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn's disease patients in relation to mucosal healingPiotr Eder, Liliana Lykowska-Szuber, Katarzyna Iwanik, et al.
Przeglad Gastroenterologiczny|April 20, 2026
RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patientsKonrad Lewandowski, Katarzyna Karłowicz, Joanna Sarbinowska, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 7, 2023
Helicobacter pylori infection is associated with increased accumulation of advanced glycation end products in the skin in patients with type 1 diabetes: A preliminary studyAgnieszka Ewa Zawada, Dariusz Naskręt, Stanisław Piłaciński, et al.
Journal of Applied Genetics|September 2, 2023
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patientsLiliana Lykowska-Szuber, Michal Walczak, Kamila Stawczyk-Eder, et al.
Archives of Medical Science : AMS|May 22, 2015
Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative studyKamila Stawczyk-Eder, Piotr Eder, Liliana Lykowska-Szuber, et al.
Scientific Reports|May 21, 2015
Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodiesPiotr Eder, Michal Michalak, Katarzyna Katulska, et al.
Archives of Medical Science : AMS|January 21, 2016
Disturbances in apoptosis of lamina propria lymphocytes in Crohn's diseasePiotr Eder, Liliana Łykowska-Szuber, Iwona Krela-Kaźmierczak, et al.
Przeglad Gastroenterologiczny|October 8, 2016
Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agentsPiotr Eder, Liliana Łykowska-Szuber, Katarzyna Katulska, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 22, 2020
Milk and dairy product consumption in patients with inflammatory bowel disease: Helpful or harmful to bone mineral density?Iwona Krela-Kaźmierczak, Michał Michalak, Aleksandra Szymczak-Tomczak, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 21, 2018
Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseasesIwona Krela-Kaźmierczak, Aleksandra Szymczak-Tomczak, Liliana Łykowska-Szuber, et al.
Folia Histochemica Et Cytobiologica|June 9, 2016
The influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn's disease patients in relation to mucosal healingPiotr Eder, Liliana Lykowska-Szuber, Katarzyna Iwanik, et al.
Przeglad Gastroenterologiczny|April 20, 2026
RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patientsKonrad Lewandowski, Katarzyna Karłowicz, Joanna Sarbinowska, et al.
Pageof 12